MX356791B - Procedimiento para la preparacion de drospirenona. - Google Patents

Procedimiento para la preparacion de drospirenona.

Info

Publication number
MX356791B
MX356791B MX2015014331A MX2015014331A MX356791B MX 356791 B MX356791 B MX 356791B MX 2015014331 A MX2015014331 A MX 2015014331A MX 2015014331 A MX2015014331 A MX 2015014331A MX 356791 B MX356791 B MX 356791B
Authority
MX
Mexico
Prior art keywords
drospirenone
dimethylene
preparation
antimineralocorticoid
carbolactone
Prior art date
Application number
MX2015014331A
Other languages
English (en)
Other versions
MX2015014331A (es
Inventor
Roberto Lenna
Francesco Barbieri
Maria Giovanna Luoni
Monica Noseda
Original Assignee
Ind Chimica Srl
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ind Chimica Srl filed Critical Ind Chimica Srl
Publication of MX2015014331A publication Critical patent/MX2015014331A/es
Publication of MX356791B publication Critical patent/MX356791B/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J53/00—Steroids in which the cyclopenta(a)hydrophenanthrene skeleton has been modified by condensation with a carbocyclic rings or by formation of an additional ring by means of a direct link between two ring carbon atoms, including carboxyclic rings fused to the cyclopenta(a)hydrophenanthrene skeleton are included in this class
    • C07J53/002—Carbocyclic rings fused
    • C07J53/004—3 membered carbocyclic rings
    • C07J53/008—3 membered carbocyclic rings in position 15/16
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/18—Feminine contraceptives

Landscapes

  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Reproductive Health (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Endocrinology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Gynecology & Obstetrics (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Steroid Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Catalysts (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)

Abstract

Se describe un procedimiento en el cual, empleando como producto de partida 17a- (3-hidroxipropil)-6ß,7ß; 15ß, 16ß-dimetilen-5ß-androstan-3ß,5,17ß-triolo (II) ó 3ß,5-dihidroxi- 6ß,7ß;15ß,16ß-dimetilen-5ß,17a-pregnano-21,17-carbolactona (III), a través de una reacción de un solo paso se obtiene drospirenona, (I), un esteroide sintético con actividad progestogéníca, antimineralocorticoide y antiandrogénica, útil para la preparación de composiciones farmacéuticas de acción anticonceptiva. (ver Fórmulas).
MX2015014331A 2013-04-12 2013-04-12 Procedimiento para la preparacion de drospirenona. MX356791B (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
PCT/IB2013/052918 WO2014167386A1 (en) 2013-04-12 2013-04-12 Process for the preparation of drospirenone

Publications (2)

Publication Number Publication Date
MX2015014331A MX2015014331A (es) 2015-12-08
MX356791B true MX356791B (es) 2018-06-12

Family

ID=48539320

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2015014331A MX356791B (es) 2013-04-12 2013-04-12 Procedimiento para la preparacion de drospirenona.

Country Status (14)

Country Link
US (1) US9556220B2 (es)
EP (1) EP2984100B1 (es)
JP (1) JP6469078B2 (es)
CN (1) CN105164144B (es)
AR (1) AR095833A1 (es)
BR (1) BR112015025816B1 (es)
CA (1) CA2909087C (es)
DK (1) DK2984100T3 (es)
ES (1) ES2630331T3 (es)
HU (1) HUE032858T2 (es)
MX (1) MX356791B (es)
PL (1) PL2984100T3 (es)
PT (1) PT2984100T (es)
WO (1) WO2014167386A1 (es)

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3042136A1 (de) 1980-11-03 1982-06-09 Schering Ag, 1000 Berlin Und 4619 Bergkamen Verfahren zur herstellung von 3 (beta), 7 (beta) -dihydroxy- (delta) (pfeil hoch)5(pfeil hoch) -steroiden
EP0075189B1 (en) 1981-09-21 1985-08-28 Schering Aktiengesellschaft 3-beta,7-beta,15-alpha-trihydroxy-5-androsten-17-one, its 3,15-dipivalate, and its preparation
DE19633685C1 (de) * 1996-08-12 1997-10-09 Schering Ag Verfahren zur Herstellung von Drospirenon (6beta,7beta;15 beta,16beta-Dimethyl-en-3-oxo-17alpha-pregn-4-en-21,17-carbolacton, DRSP) sowie 7alpha-(3-Hydroxy-1-propyl)-6beta,7beta;15beta, 16beta-dimethylen-5beta-androstan-3beta,5,17beta-triol (ZK 92836) und 6beta,7beta;15beta,16beta-dimethylen-5beta-hydroxy-3-oxo-17alpha-androstan-21,17-carbolacton (90965) als Zwischenprodukte des Verfahrens
JP4645779B2 (ja) * 2000-05-16 2011-03-09 日産化学工業株式会社 キノリンカルボアルデヒドの製造法
ITMI20040367A1 (it) * 2004-03-01 2004-06-01 Ind Chimica Srl Processo per la preparazione di drospirenone
ITMI20042338A1 (it) 2004-12-06 2005-03-06 Ind Chimica Srl Processo per la preparazione di drospirenone
DE502005004948D1 (de) * 2005-07-21 2008-09-18 Bayer Schering Pharma Ag Verfahren zur Herstellung von 3-Oxo-pregn-4-en-21,17-carbolactonen durch die metallfreie Oxidation von 17-(3-hydroxypropyl)-3,17-dihydroxyandrostanen
CN100480256C (zh) * 2006-06-21 2009-04-22 上海迪赛诺医药发展有限公司 合成曲螺酮的方法
WO2008137050A2 (en) * 2007-05-01 2008-11-13 Sicor Inc. A process for preparing drospirenone and intermediate thereof
RS51892B (en) * 2007-07-26 2012-02-29 Newchem S.P.A. DROSPIRENON PREPARATION PROCESS
CN101503455B (zh) 2009-03-11 2011-02-16 药源药物化学（上海）有限公司 一种制备屈螺酮的方法及中间体
ES2432063T3 (es) 2009-06-16 2013-11-29 Crystal Pharma, S.A.U. Procedimiento para la obtención de 17-espirolactonas en esteroides
ES2419663T3 (es) * 2010-08-03 2013-08-21 Newchem S.P.A. Métodos para la preparación de Drospirenona y productos intermedios de la misma

Also Published As

Publication number Publication date
US20160052960A1 (en) 2016-02-25
JP6469078B2 (ja) 2019-02-13
BR112015025816B1 (pt) 2021-02-02
CN105164144A (zh) 2015-12-16
PT2984100T (pt) 2017-07-14
AR095833A1 (es) 2015-11-11
WO2014167386A1 (en) 2014-10-16
HUE032858T2 (en) 2017-11-28
JP2016516095A (ja) 2016-06-02
CA2909087A1 (en) 2014-10-16
PL2984100T3 (pl) 2017-10-31
DK2984100T3 (en) 2017-07-10
BR112015025816A2 (pt) 2017-07-25
ES2630331T3 (es) 2017-08-21
US9556220B2 (en) 2017-01-31
CN105164144B (zh) 2017-03-08
EP2984100B1 (en) 2017-04-05
CA2909087C (en) 2020-01-07
MX2015014331A (es) 2015-12-08
EP2984100A1 (en) 2016-02-17

Similar Documents

Publication Publication Date Title
MX2022007432A (es) Un esteroide 19-nor-c21-n-pirazolilo c3,3-disustituido cristalino.
DK1828222T3 (da) Fremgangsmåde til fremstilling af drospirenon
EP1571153A3 (en) A process for the preparation of drospirenone
PH12020551903A1 (en) Anti-cancer nuclear hormone receptor-targeting compounds
MX2022011436A (es) Metodo de manejo de dismenorrea y dolor menstrual.
MX356702B (es) Formas de dosificación sólidas orales con dosis muy bajas para la hrt.
TW201613899A (en) Diazirine compounds and compositions derived therefrom
BR112012030810A2 (pt) "c-28 amidas de derivados de ácido c-3 betulínico modificados como inibidores de maturação de hiv"
MX2018000676A (es) Composicion adhesiva de fusion en caliente a base de polipropileno.
MX2021013774A (es) Compuestos anticancerigenos dirigidos a los receptores hormonales nucleares.
PH12017502040A1 (en) Oral care composition comprising calcium silicate
TN2015000007A1 (en) 3-substituted estra-1,3,5(10),16-tetraene derivatives, methods for the production thereof, pharmaceutical preparations containing same, and use thereof for the production of medicaments
JOP20200058A1 (ar) تصنيع تركيبات صيدلانية
MX2020002123A (es) Sales de ribociclib y formas en estado sólido de las mismas.
NO20065292L (no) Multifaseprevensjonsmiddel basert pa et naturlig ostrogen
CA2863164A1 (en) Process for the preparation of cement, mortars, concrete compositions containing calcium carbonate-based filler(s) (pre)-treated with ultrafine (uf) filler(s), compositions and cement products obtained and their applications
JOP20170029B1 (ar) C-3 وc-17 تراي تربينويد معدلة كمثبطات لـhiv-1
MX356791B (es) Procedimiento para la preparacion de drospirenona.
MY179214A (en) Methods for treatment of inflammatory conditions using s-[4-(3-fluoro-3-methylbutyryloxy)but-2-ynyl]6alpha, 9alpha- difluoro-17alpha-(furan-2-yl)carbonyloxy-11beta-hydroxy-16alpha- methyl-3-oxoandrosta-1,4-diene-17beta-carbothioate
CN106178055A (zh) 一种冰箱除臭剂
CN105461481A (zh) 一种酸性土壤改良剂
MX2018010559A (es) Procedimiento y nuevos productos intermedios para la preparacion de 11-metilen-esteroides.
CN105418053A (zh) 一种瓷砖土改良剂
PH12019501689A1 (en) Composition comprising immediate release and extended release capecitabine
PH12018501640A1 (en) C-3 and c-17 modified triterpenoids as hiv-1 inhibitors

Legal Events

Date Code Title Description
FG Grant or registration